These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39079132)

  • 1. A stemness-based signature with inspiring indications in discriminating the prognosis, immune response, and somatic mutation of endometrial cancer patients revealed by machine learning.
    Pang X; Wang Y; Zhang Q; Qian S
    Aging (Albany NY); 2024 Jul; 16(14):11248-11274. PubMed ID: 39079132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
    Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer.
    Guo Q; Qiu P; Pan K; Liang H; Liu Z; Lin J
    Sci Rep; 2024 Sep; 14(1):21449. PubMed ID: 39271768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
    Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
    BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
    Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
    Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
    Cheng P; Ma J; Zheng X; Zhou C; Chen X
    Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu.
    Snijesh VP; Krishnamurthy S; Bhardwaj V; Punya KM; Niranjana Murthy AS; Almutadares M; Habhab WT; Nasser KK; Banaganapalli B; Shaik NA; Albaqami WF
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
    Front Immunol; 2021; 12():788431. PubMed ID: 34970268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of stemness subtypes and features to improve endometrial cancer treatment using machine learning.
    Lu X; Ying Y; Zhang W; Li R; Wang W
    Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):57-73. PubMed ID: 36748358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
    Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
    Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
    Wu Y; Wang J; Ge L; Hu Q
    Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients.
    Liu M; Zhou R; Zou W; Yang Z; Li Q; Chen Z; Jiang L; Zhang J
    Stem Cell Res Ther; 2023 Sep; 14(1):238. PubMed ID: 37674202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated machine learning identifies a cellular senescence-related prognostic model to improve outcomes in uterine corpus endometrial carcinoma.
    Wei C; Lin S; Huang Y; Wei Y; Mao J; Fan J
    Front Immunol; 2024; 15():1418508. PubMed ID: 38994352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
    Tao Y; Liang B
    Pathol Res Pract; 2020 Jun; 216(6):152943. PubMed ID: 32279917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
    Ying J; Wang Q; Xu T; Lyu J
    Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.